US Stock MarketDetailed Quotes

XENE Xenon Pharmaceuticals

Watchlist
  • 42.290
  • +0.290+0.69%
Trading Dec 4 14:24 ET
3.22BMarket Cap-15049P/E (TTM)

Xenon Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-6.38%-51.15M
1.63%-32.68M
-25.48%-43.18M
-47.65%-145.33M
9.52%-29.62M
-58.14%-48.08M
-96.95%-33.22M
-86.73%-34.41M
-41.62%-98.43M
-58.05%-32.73M
Net income from continuing operations
-29.57%-62.79M
-22.05%-57.92M
-14.87%-47.93M
-45.48%-182.39M
-19.65%-44.74M
-30.45%-48.46M
-52.32%-47.46M
-112.14%-41.73M
-58.94%-125.37M
-46.28%-37.4M
Operating gains losses
121.26%64K
125.50%114K
180.00%4K
-123.45%-640K
115.59%113K
-110.16%-301K
-170.50%-447K
96.48%-5K
734.56%2.73M
-484.68%-725K
Depreciation and amortization
-61.42%669K
9.47%659K
69.21%599K
118.04%3.54M
65.24%851K
384.36%1.73M
60.53%602K
-5.85%354K
79.25%1.62M
90.74%515K
Deferred tax
-106.41%-322K
-48.66%-333K
39.93%403K
-563.64%-292K
-4,100.00%-200K
23.15%-156K
-115.38%-224K
11.63%288K
-175.86%-44K
-98.55%5K
Change In working capital
72.38%-911K
46.39%10.09M
-320.56%-5.65M
933.58%5.64M
-148.97%-522K
-37.13%-3.3M
0.04%6.89M
141.17%2.56M
74.46%-676K
5.54%1.07M
-Change in receivables
-153.55%-83K
-151.16%-22K
-83.19%38K
-92.60%130K
-119.41%-294K
2,114.29%155K
-88.97%43K
245.81%226K
482.79%1.76M
214.97%1.52M
-Change in prepaid assets
1,100.00%960K
-24.45%958K
-122.96%-673K
115.00%1.57M
60.89%-2.53M
97.85%-96K
78.34%1.27M
1,177.57%2.93M
-591.83%-10.5M
-529.70%-6.47M
-Change in payables and accrued expense
46.74%-1.79M
64.00%9.15M
-744.78%-5.02M
-51.24%3.93M
-61.76%2.3M
-263.36%-3.36M
-3.58%5.58M
89.76%-594K
171.36%8.06M
60.14%6.02M
Cash from discontinued investing activities
Operating cash flow
-6.38%-51.15M
1.63%-32.68M
-25.48%-43.18M
-47.65%-145.33M
9.52%-29.62M
-58.14%-48.08M
-96.95%-33.22M
-86.73%-34.41M
-41.62%-98.43M
-58.05%-32.73M
Investing cash flow
Cash flow from continuing investing activities
-96.33%1.98M
296.81%110.72M
-199.10%-46.2M
60.42%-117.17M
-1,613.11%-245.58M
123.02%53.88M
2,018.60%27.9M
195.36%46.62M
-19.95%-296M
93.35%-14.34M
Net PPE purchase and sale
50.83%-590K
29.02%-1.51M
91.48%-188K
-94.09%-5.62M
95.55%-78K
-210.88%-1.2M
-292.10%-2.13M
-940.57%-2.21M
-41.17%-2.89M
-240.86%-1.75M
Net investment purchase and sale
-95.33%2.57M
273.67%112.23M
-194.24%-46.01M
61.94%-111.55M
-1,851.02%-245.5M
123.57%55.08M
1,513.92%30.04M
200.31%48.83M
-19.77%-293.11M
94.15%-12.58M
Cash from discontinued investing activities
Investing cash flow
-96.33%1.98M
296.81%110.72M
-199.10%-46.2M
60.42%-117.17M
-1,613.11%-245.58M
123.02%53.88M
2,018.60%27.9M
195.36%46.62M
-19.95%-296M
93.35%-14.34M
Financing cash flow
Cash flow from continuing financing activities
26.95%353.52M
5,400,133.33%324.01M
-37.78%278.47M
-100.00%6K
Net common stock issuance
----
----
----
27.26%353.49M
--323.98M
----
----
----
-37.90%277.77M
--0
Proceeds from stock option exercised by employees
----
----
----
-95.04%35K
----
----
----
----
171.15%705K
-60.00%6K
Cash from discontinued financing activities
Financing cash flow
----
----
----
26.95%353.52M
5,400,133.33%324.01M
----
----
----
-37.78%278.47M
-100.00%6K
Net cash flow
Beginning cash position
111.82%136.73M
-15.27%58.9M
159.67%148.64M
-67.42%57.24M
-3.78%99.57M
-82.55%64.55M
-40.35%69.51M
-67.42%57.24M
290.34%175.69M
17.86%103.49M
Current changes in cash
-239.24%-49.17M
1,567.19%78.04M
-831.96%-89.38M
178.50%91.03M
203.74%48.82M
113.39%35.31M
-102.09%-5.32M
120.54%12.21M
-188.34%-115.96M
-153.59%-47.06M
Effect of exchange rate changes
118.75%54K
-156.27%-202K
-722.03%-367K
115.14%376K
-69.78%246K
89.33%-288K
140.20%359K
-79.86%59K
-319.59%-2.48M
1,079.71%814K
End cash Position
-12.00%87.62M
111.82%136.73M
-15.27%58.9M
159.67%148.64M
159.67%148.64M
-3.78%99.57M
-82.55%64.55M
-40.35%69.51M
-67.42%57.24M
-67.42%57.24M
Free cash flow
-4.99%-51.74M
3.28%-34.19M
-18.43%-43.37M
-48.97%-150.94M
13.89%-29.69M
-60.06%-49.28M
-103.04%-35.35M
-96.44%-36.62M
-41.61%-101.32M
-62.48%-34.48M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -6.38%-51.15M1.63%-32.68M-25.48%-43.18M-47.65%-145.33M9.52%-29.62M-58.14%-48.08M-96.95%-33.22M-86.73%-34.41M-41.62%-98.43M-58.05%-32.73M
Net income from continuing operations -29.57%-62.79M-22.05%-57.92M-14.87%-47.93M-45.48%-182.39M-19.65%-44.74M-30.45%-48.46M-52.32%-47.46M-112.14%-41.73M-58.94%-125.37M-46.28%-37.4M
Operating gains losses 121.26%64K125.50%114K180.00%4K-123.45%-640K115.59%113K-110.16%-301K-170.50%-447K96.48%-5K734.56%2.73M-484.68%-725K
Depreciation and amortization -61.42%669K9.47%659K69.21%599K118.04%3.54M65.24%851K384.36%1.73M60.53%602K-5.85%354K79.25%1.62M90.74%515K
Deferred tax -106.41%-322K-48.66%-333K39.93%403K-563.64%-292K-4,100.00%-200K23.15%-156K-115.38%-224K11.63%288K-175.86%-44K-98.55%5K
Change In working capital 72.38%-911K46.39%10.09M-320.56%-5.65M933.58%5.64M-148.97%-522K-37.13%-3.3M0.04%6.89M141.17%2.56M74.46%-676K5.54%1.07M
-Change in receivables -153.55%-83K-151.16%-22K-83.19%38K-92.60%130K-119.41%-294K2,114.29%155K-88.97%43K245.81%226K482.79%1.76M214.97%1.52M
-Change in prepaid assets 1,100.00%960K-24.45%958K-122.96%-673K115.00%1.57M60.89%-2.53M97.85%-96K78.34%1.27M1,177.57%2.93M-591.83%-10.5M-529.70%-6.47M
-Change in payables and accrued expense 46.74%-1.79M64.00%9.15M-744.78%-5.02M-51.24%3.93M-61.76%2.3M-263.36%-3.36M-3.58%5.58M89.76%-594K171.36%8.06M60.14%6.02M
Cash from discontinued investing activities
Operating cash flow -6.38%-51.15M1.63%-32.68M-25.48%-43.18M-47.65%-145.33M9.52%-29.62M-58.14%-48.08M-96.95%-33.22M-86.73%-34.41M-41.62%-98.43M-58.05%-32.73M
Investing cash flow
Cash flow from continuing investing activities -96.33%1.98M296.81%110.72M-199.10%-46.2M60.42%-117.17M-1,613.11%-245.58M123.02%53.88M2,018.60%27.9M195.36%46.62M-19.95%-296M93.35%-14.34M
Net PPE purchase and sale 50.83%-590K29.02%-1.51M91.48%-188K-94.09%-5.62M95.55%-78K-210.88%-1.2M-292.10%-2.13M-940.57%-2.21M-41.17%-2.89M-240.86%-1.75M
Net investment purchase and sale -95.33%2.57M273.67%112.23M-194.24%-46.01M61.94%-111.55M-1,851.02%-245.5M123.57%55.08M1,513.92%30.04M200.31%48.83M-19.77%-293.11M94.15%-12.58M
Cash from discontinued investing activities
Investing cash flow -96.33%1.98M296.81%110.72M-199.10%-46.2M60.42%-117.17M-1,613.11%-245.58M123.02%53.88M2,018.60%27.9M195.36%46.62M-19.95%-296M93.35%-14.34M
Financing cash flow
Cash flow from continuing financing activities 26.95%353.52M5,400,133.33%324.01M-37.78%278.47M-100.00%6K
Net common stock issuance ------------27.26%353.49M--323.98M-------------37.90%277.77M--0
Proceeds from stock option exercised by employees -------------95.04%35K----------------171.15%705K-60.00%6K
Cash from discontinued financing activities
Financing cash flow ------------26.95%353.52M5,400,133.33%324.01M-------------37.78%278.47M-100.00%6K
Net cash flow
Beginning cash position 111.82%136.73M-15.27%58.9M159.67%148.64M-67.42%57.24M-3.78%99.57M-82.55%64.55M-40.35%69.51M-67.42%57.24M290.34%175.69M17.86%103.49M
Current changes in cash -239.24%-49.17M1,567.19%78.04M-831.96%-89.38M178.50%91.03M203.74%48.82M113.39%35.31M-102.09%-5.32M120.54%12.21M-188.34%-115.96M-153.59%-47.06M
Effect of exchange rate changes 118.75%54K-156.27%-202K-722.03%-367K115.14%376K-69.78%246K89.33%-288K140.20%359K-79.86%59K-319.59%-2.48M1,079.71%814K
End cash Position -12.00%87.62M111.82%136.73M-15.27%58.9M159.67%148.64M159.67%148.64M-3.78%99.57M-82.55%64.55M-40.35%69.51M-67.42%57.24M-67.42%57.24M
Free cash flow -4.99%-51.74M3.28%-34.19M-18.43%-43.37M-48.97%-150.94M13.89%-29.69M-60.06%-49.28M-103.04%-35.35M-96.44%-36.62M-41.61%-101.32M-62.48%-34.48M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data